HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography

Rheumatology

Volumn 49, Issue 6, 2010, Pages 1206-1207

  Lee, Martin A ^a   Hutchinson, David G ^b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; CASE REPORT; CLINICAL EXAMINATION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOXIA; INTERSTITIAL PNEUMONIA; LETTER; LUNG FUNCTION TEST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; ISOXAZOLES; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; RADIOGRAPHIC IMAGE ENHANCEMENT; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953518823     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq002     Document Type: Letter

References (3)

1. Sawada T, Inokuma S, Sato T et al. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology 2009;48:1069-72.
2. Martin N, Innes JA, Lambert CM, Turnbull CM, Wallace WA. Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol 2007;34:1934-7.
3. Vallbracht II, Popper HH, Rieber J et al. Lethal pneumonitis under leflunomide therapy. Rheumatology 2005;44:1580-1.